Novo Nordisk sues rival over false advertising
Novo Nordisk, the maker of diabetes drug Ozempic, has filed a lawsuit against a rival company for allegedly making false claims about a competing product. The lawsuit targets advertising that may mislead consumers and healthcare providers. This case highlights ongoing legal battles in the lucrative weight-loss and diabetes drug market.